Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab

Immune checkpoint inhibitors, as nivolumab, are used in advanced non-small cell lung cancer (NSCLC). However, no associated biomarker is validated in clinical practice with this drug. We investigated herein immune-related blood markers in patients with advanced NSCLC treated with nivolumab. Plasma o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Costantini, Adrien, Julie, Catherine, Dumenil, Coraline, Hélias-Rodzewicz, Zofia, Tisserand, Julie, Dumoulin, Jennifer, Giraud, Violaine, Labrune, Sylvie, Chinet, Thierry, Emile, Jean-François, Giroux Leprieur, Etienne
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136870/
https://ncbi.nlm.nih.gov/pubmed/30221046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1452581
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados